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Available online 7 January 2016Previous neuroimaging research showed that a disgust placebo (inert pill presentedwith the verbal suggestion of
disgust relief) reduced visual cortex activation during the viewing of disgust-inducing images. In order to inves-
tigate whether this effect of automatic emotion regulation was associatedwith changed visual scanning patterns
of the pictures, we conducted two eye tracking experiments. In the ﬁrst study, 23women underwent a retest de-
sign during which they passively viewed images depicting disgusting, fear-eliciting, neutral items and fractals
both with, and without a placebo. The placebo provoked a substantial decrease in experienced disgust. Although
none of the recorded eye movement parameters (number of ﬁxations, ﬁxation duration, saccade amplitude,
blinking rate) showed placebo-related changes, placebo effects were suggested by an analysis of spatial ﬁxation
patterns. In the second study, which focused on attentional (dis)engagement, 46 women looked at two pictures
which were presented side-by-side on the screen. These picture pairs (disgust-neutral, neutral-neutral) were
once viewed with and once without a placebo. The placebo again provoked a marked decrease of experienced
disgust and enhanced the number of ﬁxations for disgusting images. This change might reﬂect a greater willing-
ness of the participants to view these stimuli while on the placebo.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Eye movements1. Introduction
A placebo is deﬁned as ‘a substance or procedure… that is objective-
ly without speciﬁc activity for the condition being treated’ (Moerman
and Jonas, 2002). The most commonly studied placebo phenomenon
is ‘placebo analgesia’, during which a patient receives a physiologically
ineffective intervention (e.g., a pill ﬁlled with sugar) with the verbal
suggestion that this is a pain-reducing treatment. Several studies were
able to demonstrate that this approach leads to pain relief as well as
to altered activation in pain-sensitive brain regions (e.g., Wager, 2005).
Investigations with a focus on other somatic response systems or on
affective processing showed that placebo effects can be relatively specif-
ic. Schienle et al. (2014a, 2014b) administered a ‘disgust placebo’, an
inert pill presented with the verbal suggestion that it reduces disgust
symptoms. Theparticipants of this functionalmagnetic resonance imag-
ing (fMRI) experiment had been asked to passively view disgusting pic-
tures once with, and once without the placebo. The placebo treatment
reduced experienced disgust as well as activation in the insula and the
visual cortex. The placebo had not evoked neuronal changes during
the presentation of fear-relevant pictures, which constituted a control
condition. Thus, the explicit verbal suggestion of disgust reductionDepartment of Psychology,
e).
. This is an open access article underinduced an emotion-speciﬁc change of brain activation. The authors
had classiﬁed this effect as automatic emotion regulation, which does
not require overt shifts of (visual) attention, insight or awareness
(Gyurak et al., 2011).
As a short-coming of this study it has to be noted that eye move-
ments had not been recorded, which would have been helpful to inter-
pret the placebo-induced reduction of visual cortex activation. Eye
tracking can be used to study scanning patterns and changes in visual
information intake. To the best of our knowledge, eye tracking has not
been used before to evaluate placebo effects. However, it has been
employed to study affective picture processing (e.g., Bradley et al.,
2011; Pannasch et al., 2008; Kaspar et al., 2013). Theﬁndings for passive
viewing designs duringwhich the participants were presentedwith im-
ages from the International Affective Picture System (IAPS; Lang et al.,
1999) were heterogeneous. Whereas Bradley et al. (2011) demonstrat-
ed that pleasant and unpleasant scenes (compared to neutral ones)
prompted more ﬁxations and broader scanning of the visual array,
Kaspar et al. (2013) found no valence-dependent effects on mean ﬁxa-
tion duration and saccade length.
On the other hand, studies which used affective pictures as mood
primes or combined the picture presentation with emotion regulation
instructions observed more homogenous effects on visual explorative
behavior (e.g., Kaspar et al., 2015; Bebko et al., 2011; van Reekum
et al., 2007; Xing and Isaacowitz, 2006). For example, van Reekum
et al. (2007) asked their participants to perform cognitive reappraisal
during the viewing of aversive pictures. When instructed to decrease
negative affect, the participants spent less time ﬁxating the picture,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ticipants looked at emotion-irrelevant details of the picturesmore in the
decrease condition than in the two other conditions. Similarly, Bebko
et al. (2011) showed that participants who conducted cognitive reap-
praisal or expressive suppression during affective picture viewing
looked away from emotion-relevant areas.
We conducted two eye-tracking experiments in order to ﬁnd out
whether a disgust placebo is able to inﬂuence visual exploration behav-
ior. In the ﬁrst study, we chose a passive viewing design as in the previ-
ous fMRI investigation (Schienle et al., 2014a). The participants were
presented with images depicting disgusting, fear-eliciting, neutral
items and fractals both with, and without placebo administration. In
the second study two pictures were presented side-by-side on the com-
puter screen followed by a reaction time task. The picture pairs
consisted of a disgust image and a neutral image or two neutral scenes.
The goal of the two exploratory studies was to investigate whether a
disgust placebo would be able to change eye movement parameters
(e.g., ﬁxation duration, number of ﬁxations, saccade amplitude) during
the viewing of disgust-inducing pictures. In addition, we investigated
the spatial exploration behavior. Previous research pointed out, that
emotional and motivational states not only inﬂuence the number and
duration of ﬁxations, but also their spatial distribution (e.g., Kaspar
and König, 2011). It is possible that placebo treatment not only alters
how long something is inspected, but also where gaze is directed in
the picture (e.g., van Reekum et al., 2007; Bebko et al., 2011).
2. Study 1
2.1. Method
2.1.1. Participants
Twenty-three healthy female students with a mean age of M =
25.4 years (SD= 6.6) participated in the experiment. They had normal
or corrected-to-normal vision, were free of somatic/mental disorders
and the intake ofmedication (as assured by the Brief Symptom Invento-
ry, Derogatis, 1993).We only included participantswith at leastmoder-
ate disgust proneness in our sample in order to assure sufﬁcient disgust
responses to the pictures. The women reported an average score on the
questionnaire for the assessment of disgust proneness (QADP) of M =
2.77 (SD = 0.3), which was signiﬁcantly higher (p b .001) than the
mean score of the construction sample (Schienle et al., 2002a, 2002b).
The sample had been restricted to women because they describe them-
selves as more disgust-prone than males. The study had been approved
by the ethics committee of the University of Graz.
2.1.2. Material and design
The participants viewed a total of 60 pictures from the categories
Disgust, Fear, Neutral and Fractal for 6000 ms each.1 The disgust scenes
showed repulsive animals (e.g., maggots, snails), poor hygiene
(e.g., dirty toilet, garbage) and unusual/spoiled food (e.g., a man eats a
grasshopper). Fear pictures showed attacks by humans or animals
(e.g., a man attacks a woman with a knife, a white shark). The neutral
pictures depicted nature scenes. The pictures had previously been
used in an fMRI study on disgust placebo effects (Schienle et al.,
2014a, 2014b). The disgust images were able to induce the target emo-
tion to a signiﬁcantly higher degree than any other basic emotion, espe-
cially fear, and therefore can be considered speciﬁc disgust elicitors.
Moreover, disgust and fear images had received comparable arousal/in-
tensity ratings (e.g. Schienle et al., 2014a). Fractals were included as an
additional control category consisting of amore homogenous set of syn-
thetic stimuli with respect to low- and high-level visual properties.1 The numbers of the IAPS pictures (Lang et al., 1999) were: disgust (9140, 9300), fear
(1300, 3500, 3530, 6212, 6230, 6312, 6350, 6370, 6510, 6540, 6940, 9910, 99,211), and
neutral 5395, 7096, 7160, 7185, 7205, 7211, 7491). The remaining pictures were taken
from validated picture sets from Schienle et al. (2002b).Thus, they allow for amore unambiguous assessment of attentional dif-
ferences between participants (Benson et al., 2007).
2.1.3. Procedure
All 23 women underwent two sessions during which they passively
viewed the pictureswhile their eyemovementswere recorded. The ses-
sions were separated by approximately one week.
In one session (the placebo condition), the participants received a
placebo pill (a 1 cm long silica-ﬁlled capsule) prior to the presentation
of the pictures. They were told that the pill contains the homeopathic
medicine Anamirta Cocculus, which is used to treat disgust-related
symptoms (nausea, diarrhea). Further, theywere informed that a previ-
ous investigation had already demonstrated that Anamirta Cocculus ef-
fectively reduces disgust symptoms, and that the positive effect occurs
approximately 15 min after the application. The efﬁcacy of the treat-
ment was investigated with a sham salivary cortisol measurement. An
absorbent swab was placed into the mouth of each participant subse-
quent to the picture viewing. This procedure was introduced in order
to direct participants' attention away from the eye tracking.
In the other session (No-placebo condition), the participants re-
ceived no capsule and viewed the same pictures. The sequence of the
pictures within one session was random. The sequence of the two ses-
sions (Placebo, No-placebo) was counterbalanced (12:11) across
participants.
Subsequent to the eye tracking sessions, the participants were pre-
sented with four sheets of paper depicting the 15 pictures representing
an affective category (Disgust, Fear, Neutral, Fractal). They were asked
to rate the intensity of elicited fear and disgust for each category by
means of 9-point Likert scales (1= little; 9=very intense).Mean judg-
mentswere obtained for each of the four picture categories. The order of
the sheets was randomized to control for sequence effects.
The study was conducted at the University Hospital in Graz, and the
experimenters wore white coats during the conduction of the study in
order to enhance the credibility of the cover story.
2.1.4. Eye movement recording and analysis
We recorded two-dimensional eye movements using an Eye-Link II
eye tracker (SR Research, Canada). The eye tracker is a head-mounted
system that uses two infra-red cameras that monitor the eyes at a sam-
pling rate of 250 Hz. It also uses a headmovement compensationmech-
anism. We calibrated both eyes and recorded from the eye that
produced the superior spatial resolution, which was better than 0.35°
visual angle (v.a.). Displays were presented on a 17-in. TFT monitor
with a resolution of 1280 × 1024 pixels running at 60 Hz. All pictures
had a size of approximately 20° × 15° v.a. and were presented on a
gray background. Participants were seated in a dimly lit room in front
of the monitor with a viewing distance of 60 cm. A chin rest was used
tominimize headmovements. The velocity threshold for saccade detec-
tionwas set to 35°/s, the acceleration thresholdwas set to 9500°/s2. Fix-
ations were deﬁned by the absence of a saccade. The eye tracker was
calibrated before the recording using a 9-point calibration procedure.
At the beginning of each trial, a white ﬁxation cross was presented in
the center of the screen on a gray background. The trial was started by
the experimenter only when the ﬁxation on the cross was registered.
This step took no longer than 1000ms. It also served as a drift correction
of the eye tracker. Immediately thereafter, a picture was presented for
6000 ms. The experiment was controlled with the Experiment Builder
software (SR Research, Canada). Data analysis was conducted using
DataViewer software (SR Research, Canada) and custom-written
MATLAB scripts.
We analyzed the number of ﬁxations, mean ﬁxation duration, mean
saccade amplitude, number of blinks for each picture category (Disgust,
Fear, Neutral, Fractal) and compared them between the two conditions
(Placebo, No-placebo). In order to investigate the spatial distribution of
ﬁxations, we divided each picture into 16 rectangular regions of size
5.0° × 3.75°, forming a 4 × 4 grid. We counted the number of ﬁxations
Table 2
Correlations of ﬁxation counts for the 16 regions of an image (labeled A1,…, D4) between
the Placebo and No-placebo condition for each of the four picture categories (Study 1).
Disgust 
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ﬁcients for each region between the Placebo and No-placebo condition
across all participants (see Kaspar and König, 2011). The coefﬁcients re-
ﬂect the extent to which corresponding regions of the pictures received
a similar amount of visual attention under both experimental
conditions.
3. Results
3.1. Affective ratings
We conducted analyses of variance for repeated measures with the
within-subjects factors Picture Category (Disgust, Fear, Neutral, Fractal),
Treatment (Placebo, No-placebo) and Rating Type (disgust, fear) for the
affective ratings. We observed signiﬁcant main effects for Picture Cate-
gory (F(2.01,46.07) = 82.87, p b .001, η2p = .790), Treatment
(F(1,22) = 118.51, p b .001, η2p = .843) and Rating Type (F(1,22) =
22.07, p b .001, η2p = .501). All two way interactions and the three-
way interaction were signiﬁcant (all p's b .001; all η2p N .587). Ratings
for disgust pictures were generally higher than for the other categories.
Disgust ratings were higher than fear ratings. Without placebo partici-
pants rated the pictures higher with respect to both fear and disgust.
Post-hoc t-tests showed that only for the disgust pictures the ratings
were reduced by the placebo (t(22) = 18.57, p b .001, d = 4.48; see
Table 1).
3.2. Eye movements
The conducted analyses of variance for repeated measures with the
within-subjects factors Picture Category (Disgust, Fear, Neutral, Fractal)
and Treatment (Placebo, No-Placebo) revealed signiﬁcant main effects
of Picture Category for number of ﬁxations (F(3,66) = 13.06, p b .001,
η2p= .37),ﬁxation duration (F(3,66)=4.97, p= .004,η2p= .19), sac-
cade amplitude (F(3,66) = 15.35, p b .001, η2p = .41), and number ofTable 1
Affective ratings and eye movement parameters for the four picture categories in the Pla-
cebo and No-placebo condition (Study 1).
No-placebo
M (SD)
Placebo
M (SD)
Disgust pictures
Experienced disgust 8.04 (0.82) 2.91 (1.34)
Experienced fear 2.57 (1.19) 1.83 (1.26)
Number of ﬁxations 17.36 (2.72) 17.97 (2.93)
Fixation duration (ms) 287.23 (35.40) 283.18 (40.29)
Saccade amplitude (deg. v.a.) 4.29 (0.76) 4.33 (0.55)
Number of blinks 0.90 (0.87) 0.84 (0.72)
Fear pictures
Experienced disgust 2.87 (1.91) 2.13 (1.14)
Experienced fear 4.39 (2.38) 3.13 (1.71)
Number of ﬁxations 16.65 (3.03) 16.92 (2.95)
Fixation duration 289.42 (33.46) 287.42 (30.98)
Saccade amplitude (deg. v.a.) 4.51 (0.74) 4.62 (0.60)
Number of blinks 0.90 (0.94) 0.93(0.70)
Neutral pictures
Experienced disgust 1.13 (0.45) 1.00 (0.00)
Experienced fear 1.04 (0.20) 1.04 (0.20)
Number of ﬁxations 15.23 (3.21) 16.44 (2.53)
Fixation duration (ms) 300.96 (33.37) 294.58 (33.32)
Saccade amplitude (deg. v.a.) 4.04 (0.69) 4.14 (0.62)
Number of blinks 1.14 (1.03) 1.20 (0.87)
Fractal pictures
Experienced disgust 1.26 (1.05) 1.48 (1.20)
Experienced fear 1.22 (0.67) 1.30 (0.70)
Number of ﬁxations 16.46 (2.61) 16.78 (2.77)
Fixation duration (ms) 290.81 (31.70) 291.59 (36.94)
Saccade amplitude (deg. v.a.) 4.44 (.88) 4.59 (.72)
Number of blinks 1.09(1.09) 1.17 (1.02)blinks per picture (F(3,66) = 7.74, p = .002, η2p = .26) (see Table 1).
The effects for Treatment as well as for the interaction Picture
Category × Treatment did not reach statistical signiﬁcance (all
p's N .30; see Table 1).
The post-hoc t-tests indicated that the number of ﬁxations was
higher for Disgust pictures than for any other picture category
(p's b .002; all d's N .31). As number of ﬁxations and ﬁxation duration
are reciprocally related if presentation time is ﬁxed, ﬁxation duration
was shorter for Disgust pictures relative to Neutral pictures (p b .001,
d = 0.35). A marginally signiﬁcant difference was obtained for Fear
and Neutral pictures with shorter durations for the aversive condition
(p = .06).
Disgust pictures were associated with smaller saccade amplitudes
than Fear and Fractal pictures (p's b .009, d's N .35); the difference be-
tween Disgust pictures and Neutral pictures was marginally signiﬁcant
(p = .06). Smaller saccade amplitudes characterized Neutral pictures
relative to Fear, and Fractal pictures (p's b .001, d's N .56). Finally, the
blinking rate was smaller for Disgust and Fear pictures relative to Neu-
tral images (p's b .004, d's N .29).
To analyze ﬁxation distributions we correlated the ﬁxation counts
for each of the 16 picture regions in the Placebo condition with the re-
spective counts in the No-placebo condition (see Table 2).We observed
9 (Neutral) and 13 (Fractal) signiﬁcant correlations for the non-affective
categories, while the corresponding numbers were considerably small-
er for Fear (5) and Disgust (5). Moreover, we calculated an ANOVAwith
Treatment and Picture Category as within-subjects factors for the aver-
age number of inspected regions per picture. We observed a signiﬁcant
main effect for Picture Category (F(3,66)= 27.72, p b .001; η2p= .558)A B C D 
1 .338 .281 .298 .266 
2 .609* .634* .648* .508 
3 .284 .334 .588* .366 
4 .767* .221 .304 .477
Fear 
1 .249 .468 .309 .621* 
2 .507 .611* .692* .428
3 .632* .410 .701* .088 
4 .231 .384 .235 .214 
Neutral 
1 .505 .131 .280 .643*
2 .447 .658* .716* .514
3 .774* .680* .395 .009 
4 .419 .775* .692* .481
Fractal 
1 .755* .637* .673* .566* 
2 .719* .779* .554 .079 
3 .662* .716* .594* .368* 
4 .630* .722* ..511 .583* 
⁎p b .003 (Bonferroni corrected).
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.051; η2p = .162). The interaction was not signiﬁcant (F(3,66) =
1.55, p = .209). More regions of the Disgust images were viewed com-
pared with Fear and Neutral pictures. Additionally, more regions of
Fractals were inspected compared with Fear and Neutral images (all
p's b .001, d's N 1.39; Table 3). While on the placebo fewer regions of
the Disgust and Neutral pictures (p's b .035; d's N .664) were looked
at, while this was not the case for the other two picture categories
(p's N .21).4. Discussion of Study 1
We administered a disgust placebo, which caused a marked reduc-
tion of disgust feelings. This ﬁnding is in line with previous placebo
studies with a similar design (Schienle et al., 2014a; Übel et al., 2015).
Moreover, the placebo effect was disgust-speciﬁc, which underlines
the differential validity of the treatment on the self-report level.
In contrast, the basic eye movement parameters did not reveal
placebo-associated changes. We were only able to demonstrate that
the participants showedmore ﬁxations and smaller saccade amplitudes
when looking at the disgusting pictures relative to the other categories.
Thus, the repulsive scenes received a speciﬁc type of visual analysis. This
exploration patternmight be explainedwith the disease-avoidance the-
ory of disgust (Davey, 2011). Disgust helps us to detect and evaluate the
contamination properties of a stimulus. For example, it is important to
decide whether a piece of food is completely rotten or whether only a
small part is spoiled (Schienle et al., in press). Consequently, it is impor-
tant to get a quick overview.
The analysis of the spatial ﬁxation patterns had indicated that the
number of inspected regions declined while on the placebo (most nota-
bly for Disgust and Neutral pictures). This implies that the ﬁxation clus-
tering slightly increased. In addition, we observed a smaller
correspondence in terms of the extent of spatial exploration between
the Placebo and No-Placebo condition for the Disgust and Fear pictures
(as indexed by lower correlation coefﬁcients) compared to Fractal and
Neutral scenes. Most likely, during placebo administration the ﬁxation
clusters shrunk and covered different regions of the aversive pictures.
Despite clear emotion-speciﬁc effects, the placebo effects on eye
movement were either absent or ambiguous. Possible reasons for the
absence of a placebo effect might relate to the speciﬁc design of the
study. We used a passive viewing design, during which participants
conducted no speciﬁc task. This can result in a reduced involvement
and consequently superﬁcial processing of the stimulus. Moreover, not-
withstanding the extremely large placebo effect on the subjective level,
a bigger sample size could have been necessary to identify such effects
on eye movement parameters. Finally, fractals were possibly not an op-
timal choice as they showed a rather broad spatial distribution of
object-like image content relative to disgusting and fear-eliciting im-
ages, which more often depicted only one or a few localized emotion-
speciﬁc elicitors. We attempted to overcome these limitations in Study
2 which used a more elaborate design, without fractals, to analyze
placebo-associated changes of visual exploration as well as a bigger
sample size. This studywas designed to speciﬁcally investigate process-
es of visual (dis)engagement.Table 3
Average number of inspected regions per picture of a category (Study 1).
No-placebo
M (SD)
Placebo
M(SD)
Disgust 7.04 (0.88) 6.68 (0.93)
Fear 6.38 (0.67) 6.33 (0.85)
Neutral 6.18 (0.92) 5.77 (0.91)
Fractal 7.29 (1.14) 7.03 (1.18)5. Study 2
5.1. Method
5.1.1. Participants
Forty-six healthy womenwith a mean age of M= 22.5 years (SD=
3.5) took part in the experiment. As in the ﬁrst study participants had
normal or corrected-to-normal vision and did not suffer from somatic
or mental disorders (as assured by the BSI, Derogatis, 1993). We again
selected subjects with at least average disgust proneness; the reported
QADP score was M = 2.14 (SD = .59). The study had been approved
by the ethics committee of the University Graz.5.1.2. Material and design
Forty-eight picture pairs were presented side by side on a white
background on the computer screen: 32 pairs consisted of one disgust
image and one neutral image, 16 pairs showed two neutral images2
(see Fig. 1). All picture pairs had a size of 24.5° × 14° v.a. For half of
the picture pairs the disgust image was presented on the left side of
the screen (Disgust–Neutral), for the other half on the right side (Neu-
tral–Disgust). Prior to the presentation of the picture pair we showed
a black ﬁxation circle on a white background located at the center of ei-
ther the left or right image of the pair to be shown. This was done in
order to direct the ﬁrst ﬁxation to the location of the subsequently
showndisgust or neutral image. As soon as a stable ﬁxation on this circle
was registered the display switched to the presentation of the picture
pair. We were interested in the time subjects took to direct their atten-
tion to the disgusting imagewhen theﬁrst ﬁxation had beenon theneu-
tral image. This duration (‘ﬁrst ﬁxation latency’) was considered an
indicator of attentional capture of motivated attention to disgust. Also,
we studied how long the subjects viewed the disgust image (when
the ﬁrst ﬁxation had been on the disgust image) before looking away
to the neutral image as an indicator of attentional disengagement.
The order of the picture pairswas randomized aswell as the location
of the ﬁxation circle. Picture pairs were shown for 7000 ms each. After
the presentation of a picture pair, a black square of 4° × 4° v.a. was pre-
sented at the center of either the left or right image on a white back-
ground. The participants were instructed to press the left or right
mouse button as fast as possible when the square appeared on the cor-
responding side of the display. An example of a trial is shown in Fig. 1.5.1.3. Procedure and eye movement recording
As in the ﬁrst study the two sessions (Placebo, No-Placebo) were
separated by about one week and counterbalanced. The administration
of the placebo was similar to Study 1. After the eye-tracking session,
participants rated the pictures. We showed them sheets of paper with
the disgust or the neutral pictures and they had to judge experienced
arousal and disgust with 9-point Likert scales (1 = little; 9 = very in-
tense; the order of sheets was counterbalanced). Again, the study was
conducted at the University Hospital in Graz, and the experimenters
wore white coats to enhance the credibility of the cover story.
We used an Eye-Link I eye tracker (SR Research, Canada). The cali-
bration procedure and the recorded parameters were identical to the
ﬁrst study; only the spatial resolution was slightly lower. The picture
pairs were presented on a 24-in. TFT monitor.2 Neutral images were IAPS pictures 1450, 5260, 5390, 5470, 5520, 5711, 5731, 7010,
7034, 7036, 7041, 7050, 7080, 7140, 7150, 7175, 7185, 7190, 7195, 7224, 7230, 7501,
7600, 7820; 1333, 2393, 2880, 5030, 5201, 5300, 5395, 5593, 5811, 5875, 5900, 7000,
7002, 7030, 7073, 7096, 7100, 7161, 7179, 7205, 7491, 7493, 7495, 7570, 7950, 8030
(Lang et al., 1999); the remaining neutral and disgust pictures were taken from picture
sets by Schienle et al. (2002b)
Fig. 1. Sequence of events in a trial (Study 2).
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5.1.4.1. Affective ratings.We conducted analyses of variance for repeated
measures for the affective ratings (disgust, arousal). Thewithin-subjects
factors were Treatment (Placebo, No-Placebo) and Picture Category
(Disgust, Neutral). For the disgust ratings the main effects CategoryTable 4
Affective ratings and eye movement parameters in the placebo and no-placebo condition
(Study 2).
No-placebo
M (SD)
Placebo
M (SD)
Disgust pictures
Experienced disgust 5.54 (1.67) 3.43 (1.71)
Arousal 3.50 (1.84) 2.70 (1.74)
Number of ﬁxations 12.55 (3.35) 13.56 (3.31)
Fixation duration (ms) 292.51 (45.3) 296 (46.59)
Neutral pictures
Experienced disgust 1.11 (0.38) 1.13 (0.4)
Arousal 1.52 (1.01) 1.35 (.82)
Number of ﬁxations 9.08 (2.17) 8.84 (2.31)
Fixation duration (ms) 317.30 (86.3) 328.11 (105.73)
Picture pairs: disgust–neutral
Number of ﬁxations 25.63 (3.19) 25.47 (3.49)
Fixation duration (ms) 303.09 (68.73) 311.90 (88.07)
Saccade amplitude (deg. v.a.) 6.14 (1.04) 6.15 (.86)
Number of blinks 1.50 (1.21) 1.58 (1.38)
Picture pairs: neutral–neutral
Number of ﬁxations 25.83 (3.2) 25.55 (3.33)
Fixation duration (ms) 298.33 (57.32) 315.01 (75.61)
Saccade amplitude (deg. v.a.) 6.77 (1.25) 6.94 (1.04)
Number of blinks 1.53 (1.24) 1.46 (1.29)(F(1,45) = 354,93, p b .001, η2p = .887) and Treatment (F(1,45) =
43,84, p b .001, n2p = .493) were signiﬁcant. Disgust pictures were
rated as more disgusting than neutral pictures and under the inﬂuence
of a placebo pictures were rated as less disgusting. The interaction
Category × Treatment (F(1,45)= 45.78, p b .001, η2p = .504) was sig-
niﬁcant as well. Only the ratings for the Disgust pictures were lowered
by the placebo (t(45) = 6.78, p b .001, d = 1.25; see Table 4).
For arousal, the main effects Category (F(1,45) = 65.78, p b .001,
η2p = .594) and Treatment (F(1,45) = 7.71, p = .008, η2p = .146)
and the interaction were signiﬁcant (F(1,45) = 4.60, p = .037, η2p =
.093). Post-hoc t-tests revealed that only the rating for the Disgust pic-
tures were altered by the placebo (t(45) = 2.8, p = .008, d = .45; see
Table 4).
5.1.4.2. Eye movements. First, we conducted an analysis of variance with
the factors Picture Pair (Disgust-Neutral vs. Neutral–Neutral) and Treat-
ment conditions (Placebo, No-Placebo) for the eye-movement parame-
ters (number of ﬁxations, mean ﬁxation duration, mean saccade
amplitude and number of blinks). The ANOVA revealed a statistically
signiﬁcant main effect of Treatment for the mean ﬁxation duration
(F(1,45) = 4.17, p = .047, η2p = .085) and a signiﬁcant main effect
of Picture Pair for mean saccade amplitude (F(1,45) = 118.38,
p b .001, η2p = .725). The ﬁxation durations were longer when aTable 5
Dwell times (total ﬁxation time in ms) for Study 2.
No-placebo
M (SD)
Placebo
M (SD)
Mean
Disgust 3522.15 (813.34) 3888.02 (850.81) 3705,08 (761.29
Neutral 2733.70 (882.62) 2704.98 (919.82) 2719,34 (842.38)
Mean 3127.92 (163.67) 3896.50 (165.83)
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duced the mean saccadic amplitude. The other main effects and the in-
teractions were not signiﬁcant (p's N .10).
In a further step, we restricted our analysis to trials with Disgust-
Neutral pairs (combined Disgust-Neutral, Neutral-Disgust). This
means we analyzed the eye tracking data from the disgust image and
the neutral image separately, and considered each image as an area of
interest. We compared the eyemovement measures between these im-
ages (factor Category) similar to Study 1. For number of ﬁxations both
main effects were signiﬁcant (Category: F(1,45) = 39.27, p b .001,
η2p = .466; Treatment: F(1,45) = 10.11, p = .003, η2p = .184), as
well as the interaction (F(1,45) = 5.13, p = .028, η2p = .102). The
main effect Category was also signiﬁcant for themean ﬁxation duration
(F(1,45) = 7.81, p = .008, η2p= .148; see Table 3), while the main ef-
fect Treatment and the interaction did not reach signiﬁcance (p's N .40).
The participants made more ﬁxations on disgust images than they did
on neutral images during the presentation of a picture pair. While on
the placebo more ﬁxations were made. Post-hoc t-tests showed that
the placebo only increased the ﬁxation count for the disgust images
(t(45) = 3.09, p = .003, d = .30; see Table 5).
We then analyzed theﬁrstﬁxation latency as indicator of attentional
(dis)engagement. The main effect of Category (F(1,45) = 236.72,
p b .001; η2p= .843) showed that participants looked faster to the dis-
gust image when the ﬁrst ﬁxation was on the neutral image (M =
660.12 ms, SD = 61.17) than they did the other way around (M =
1701.32 ms, SD = 102.90). The main effect Treatment and the interac-
tion did not reach statistical signiﬁcance (p's N .90).
Finally, we analyzed whether dwell times (total ﬁxation duration)
differed between disgust and neutral images of a pair andwe conducted
an analysis of variance for repeatedmeasures with Picture Category and
Treatment as within-subjects factors. The analysis showed two signiﬁ-
cant main effects (Category: F(1,45) = 18.02, p b .001, η2p = .286;
Treatment: F(1,45)=116.09, p b .001,η2p= .721), and a signiﬁcant in-
teraction Category × Treatment (F(1,45)=4.25, p= .045, η2p= .086).
Dwell times on the disgust images were longer than on the neutral im-
ages (see Table 5). While on the placebo the participants spent more
time ﬁxating the images. The post-hoc t-tests revealed that the placebo
only increased the time spent on the disgust images (t(45) = 3.67, p =
.001, d = .44).
6. Discussion of Study 2
Replicating the ﬁndings of the ﬁrst experiment, the placebo-
associated positive suggestion of disgust relief was again very effective
on the self-report level. In Study 2, the pronounced reduction of experi-
enced disgust was accompanied by changes in visual exploration. Fixa-
tion durations were generally longer in the Placebo condition than in
the No-placebo condition. Even in trials with only neutral pictures
they were longer under the inﬂuence of a placebo. This indicates that
participants allowed themselves more processing time for a single ﬁxa-
tion instead of moving their eyes more frequently when they received
the treatment. This is in line with the arousal ratings which showed a
general placebo-related reduction.
We observed no placebo-related changes of the ﬁrstﬁxation latency,
when subjects either looked towards the Disgust pictures or away from
them for the ﬁrst time. The placebo was not able to change these early
shifts of selective attention (engagement to vs. disengagement from
the disgust stimulus). Nevertheless, the timing of these responses
(e.g., the mean disengagement duration of 1700 ms) was similar to
eye-tracking studies with a similar design. Pﬂugshaupt et al. (2005) re-
ported that avoidance of spider pictures in phobics started 1700 ms
after picture onset.
The separate analysis of neutral and disgust images from the com-
bined Disgust-Neutral trials revealed that the participants made more
ﬁxations on the disgust pictures. This effect was ampliﬁed by the place-
bo. The analysis of the dwell times showed that only the time spent onthe disgust images, but not on the neutral images, had been changed by
the placebo.7. General discussion
We demonstrated that disgust placebos are able to provoke marked
and speciﬁc reductions of disgust feelings. In a previous neuroimaging
study (with the same pictures) the placebo-induced disgust reduction
had been accompanied by activation changes in disgust-relevant brain
areas such as the insula (Schienle et al., 2014a). In addition, visual cortex
recruitment had been changed due to the placebo application (Schienle
et al., 2014b). The authors interpreted their ﬁndings as a consequence of
automatic emotion regulation, but could not exclude the possibility that
altered eye movements indexing changes of visual attention had con-
tributed to this result.
With our ﬁrst eye tracking study, we were not able to identify
placebo-induced changes in basic eye movement parameters such as
number of ﬁxations and saccade amplitude. We had shown one image
at a timewith no speciﬁc task. However, an analysis of the spatial distri-
bution of ﬁxations suggested that the placebo was able to alter visual
exploration behavior. The participants started to look at different areas
of Disgust and Fear pictures while on the placebo, and showed a
more clustered Disgust exploration. The goal of future eye-tracking in-
vestigations should include a region of interest (ROI) approach, which
focuses on such areas of a picture that are crucial for emotion elicitation
in order to specify placebo-related attentional (dis)engagement.
The second study clearly showed that the disgust placebo altered
processes of visual attention.We presented two pictures simultaneous-
ly; either two neutral images or one neutral and one disgust image.
Through this modiﬁcation of the experimental design we were able to
identify speciﬁc eye movement characteristics, which were inﬂuenced
by the placebo. The placebo generally increased the ﬁxation duration
and reduced arousal, which might mirror the generally calming inﬂu-
ence of a placebo. We have observed similar unspeciﬁc placebo effects
in one of our EEG studies (Übel et al., 2015). Here, the disgust placebo
reduced experienced disgust and enhanced late frontal positivity as an
indicator of directed, controlled attention towards the disgust images.
In addition, late positivity was also enhanced towards fear images
while on the disgust placebo. Obviously the placebo effect had
generalized.
More importantly, the disgust placebo speciﬁcally increased the
number of ﬁxations for the target images. Accordingly, the analysis of
the dwell times on the disgust and neutral images of a pair indicated
that only the time spent on the disgust images, but not on the neutral
images, had been changed by the placebo. It seems that because partic-
ipants perceived less disgust, they more willingly looked at the disgust
pictures. Disgust stimuli typically repel gaze, and this effect seems driv-
en by levels of disgust experienced in response to the stimulus
(Armstrong et al., 2014). When disgust is dampened efﬁciently then
there is no need any more to avoid or suppress the viewing in order to
regulate the emotion.
The placebo-related changes of visual exploration clearly differ from
those reported for cognitive reappraisal. This conscious and effortful
emotion regulation strategy involves changing how one evaluates a sit-
uation. van Reekum et al. (2007) showed that the participants looked at
emotion-irrelevant details of the pictures more often when they active-
ly tried to decrease negative affect. In contrast, while on the placebo our
participants spent more time looking at disgust pictures.
It is an interesting question for future research, whether patients
with mental disorders which are characterized by excessive and
difﬁcult-to-control disgust feelings (e.g., washing compulsions, blood
phobia) could proﬁt from a ‘disgust placebo’. This type of treatment
might constitute a ﬁrst step of psychotherapy, which helps the patients
to (visually) approach and explore the disorder-relevant stimuli during
exposure therapy. The investigation of such clinical groups in
75A. Schienle et al. / International Journal of Psychophysiology 101 (2016) 69–75combination with elaborate analyses of spatial visual exploration pat-
terns seems very promising.
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